Incipiam Pharma
PrivateLast Round
Accelerator
Feb 25, 2025
Total Funding Raised
$520,000
Company Overview
Incipiam Pharma operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was an Accelerator round in February 2025.
Incipiam Pharma is a biotechnology company that develops small molecule drugs targeting energy expenditure to treat obesity and diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Incipiam Pharma Comparables
Compare Incipiam Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Energesis Pharmaceuticals, Inc. | 84% | |
| Embark Laboratories | 83% | |
| Continuum Biosciences | 79% |
For institutional investors. Book with your work email.
Incipiam Pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Incipiam Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2025
$520K round led by BioInnovation Institute
For institutional investors. Book with your work email.
Incipiam Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Incipiam Pharma's valuation, stock price, and market status.
Is Incipiam Pharma a public or private company?
Incipiam Pharma is a private company.
What is the current stock price of Incipiam Pharma?
Incipiam Pharma is a private company, so its shares have no public market price. Caplight tracks Incipiam Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Incipiam Pharma worth (valuation)?
Valuation information for Incipiam Pharma is not publicly available.
Can I buy Incipiam Pharma stock?
Incipiam Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Incipiam Pharma's last funding round?
Incipiam Pharma's most recent funding round was Accelerator on February 25, 2025.
Who are the main investors in Incipiam Pharma?
Key investors in Incipiam Pharma include BioInnovation Institute.
Will Incipiam Pharma IPO soon?
No public IPO plans have been announced for Incipiam Pharma.
How can I track Incipiam Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Incipiam Pharma's shares on secondary markets.